FGF21 and metabolic dysfunction-associated steatotic liver disease: Given that leptin levels are increased in MASLD patients,21 and leptin promotes insulin resistance,22 we consider the negative relationship between FGF21 and LEPR as highly suggestive for FGF21 to improve insulin sensitivity by dampening leptin signalling.